Total cases (n = 20) | Metastatic cases (n = 7) | |
---|---|---|
Mean age (±SD) | 48. 3 (±11,84) | 45.86 (±12.9) |
≤ 45 | 10 | 4 (57.2 %) |
> 45 | 10 | 3 (42.8 %) |
FIGO Stage | ||
I A | 4 (20 %) | 0 - |
I B | 10 (50 %) | 4 (57.1 %) |
II A | 3 (15 %) | 1 (14.3 %) |
II B | 2 (10 %) | 1 (14.3 %) |
III B | 1 (5 %) | 1 (14.3 %) |
Histopathology | ||
Squamous cell carcinoma (SCC) | 16 (80 %) | 6 (85.8 %) |
Adenocarcinoma (AC) | 4 (20 %) | 1 (14.2 %) |
Grading | ||
Well differenziated (G1) | 2 (10 %) | 1 (14.2 %) |
Moderately differentiated (G2) | 6 (30 %) | 1 (14.2 %) |
Poorly differentiated (G3) | 12 (60 %) | 5 (71.6 %) |
Volume of primary lesion | ||
< 2 cm | 4 (20 %) | 0 - |
2-4 cm | 3 (15 %) | 2 (28.6 %) |
> 4 | 2 (10 %) | 2 (28.6 %) |
Tumor Invasion | ||
Peri-tumor tissues | 3 (15 %) | 3 (42.9 %) |
Lymph nodes | 3 (15 %) | 3 (42.9 %) |
Peri-tumor + Lymph nodes | 1 (5 %) | 1 (14.2 %) |